folder Filed in Funding daily
Biotech Startup Prilenia Picked up $43 Million in a Series B Funding Round
By Tsani Gramatikova access_time 1 min read

What is Prilenia?

Prilenia is a biotechnology services provider.

What does Prilenia do?

The company develops treatments for neurodegenerative and neurodevelopmental disorders.

Who owns Prilenia?

Michael R Hayden founded Prilenia in 2018.

How much has Prilenia raised?

The company picked up $43 million in a Series B funding round that brings the company’s total financing to $105.5 million in funding over two rounds.

Who has invested in Prilenia?

ALS Investment Fund and six other investors backed the latest investment round.

What domain name does Prilenia operate on?

You can see Prilenia mean business by looking at their domain name choices – the brand has secured, an exact brand match name with the global .com extension.

Premium domain names are a valuable asset for businesses looking to build a strong, professional brand. If you’re interested in purchasing a premium domain name for your business, don’t hesitate to contact us for more information and assistance.

Biotech biotechnology branding business domain domain name domains funding naming Prilenia provider services startup